XML 17 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 10,028 $ 15,174
Short-term investments 95,453 102,485
Trade receivables, net 67,145 59,864
Gross inventories 149,417 150,192
Less LIFO reserve (66,398) (64,262)
Less excess and obsolescence reserve (6,533) (6,120)
Net inventories 76,486 79,810
Prepaid expenses and other current assets 9,245 14,062
Total Current Assets 258,357 271,395
Property, plant and equipment 477,622 462,397
Less allowances for depreciation (406,373) (390,863)
Net property, plant and equipment 71,249 71,534
Deferred income taxes 16,681 11,976
Other assets 37,747 43,912
Total Assets 384,034 398,817
Current Liabilities    
Trade accounts payable and accrued expenses 35,750 31,708
Contract liabilities with customers (Note 2) 149
Product liability 431 634
Employee compensation and benefits 18,824 24,660
Workers’ compensation 5,804 6,044
Total Current Liabilities 60,809 63,195
Lease liability (Note 7) 1,747 2,170
Employee compensation 1,835 1,685
Product liability accrual 61 46
Contingent liabilities (Note 20)
Stockholders’ Equity    
Additional paid-in capital 50,536 46,849
Retained earnings 436,609 418,058
Less: Treasury stock – at cost 2024 – 7,677,159 shares 2023 – 6,978,400 shares (192,031) (157,623)
Total Stockholders’ Equity 319,582 331,721
Total Liabilities and Stockholders’ Equity 384,034 398,817
Nonvoting Common Stock    
Stockholders’ Equity    
Common Stock, Value
Common Stock    
Stockholders’ Equity    
Common Stock, Value $ 24,468 $ 24,437